# Evaluation of Early Association of Terlipressin and Norepinephrine During Septic Shock; the TerliNor Study

> **NCT03336814** · PHASE4 · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 40 (estimated)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Terlipressin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03336814
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-27
- **Primary completion:** 2018-12-01
- **Final completion:** 2019-06-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2018-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03336814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03336814, "Evaluation of Early Association of Terlipressin and Norepinephrine During Septic Shock; the TerliNor Study". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03336814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*